Literature DB >> 12393287

Isolated cardiac recurrence of acute lymphoblastic leukemia characterized by t(11;19) two years after unrelated allogeneic bone marrow transplantation.

Tonya L Wright1, Peter G Bardy, Patrick Disney, Sarah Moore, Noemi Horvath.   

Abstract

A 33-year-old male presented with acute lymphoblastic leukemia (ALL) characterized by translocation (11;19)(q23;p13.3). He received an allogeneic bone marrow transplant from a matched unrelated donor. Two years later his disease relapsed with an isolated intracardiac mass, presenting as right heart failure. He had no evidence of concomitant relapse in the bone marrow. Tumor cytogenetics revealed clonal evolution with the karyotype 46,XY,t(3;16)(q23;p13),t(11;19)(q23;p13.3), the chromosome 16 breakpoint involving the band where the genes for multidrug resistance-associated protein and CREB binding protein are known to reside. To our knowledge, this is the first report of an isolated extramedullary relapse of ALL in the heart.

Entities:  

Mesh:

Year:  2002        PMID: 12393287     DOI: 10.1016/s0165-4608(02)00559-9

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

1.  Cardiac Relapse of Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  María Facenda-Lorenzo; Ana Sánchez-Quintana; Alejandro Quijada-Fumero; Ana Laynez-Carnicero; Joaquín Breña-Atienza; Francisco J Poncela-Mireles; Juan M Llanos-Gómez; Ana I Cabello-Rodríguez; María Ramos-López
Journal:  Case Rep Oncol Med       Date:  2016-08-23

2.  Fibrinous and hemorrhagic pericarditis with cardiac tamponade due to acute myeloid leukemia.

Authors:  Magda Zanelli; Maurizio Zizzo; Francesca Sanguedolce; Maria Elena Laurenti; Angelo Genua; Marina Moretti; Giovanni Martino; Alessandra Soriano; Stefano Ascani
Journal:  Pathologica       Date:  2021-12

3.  An isolated cardiac relapse after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia.

Authors:  Kiju Chang; Dae-Young Kim; Kyoo-Hyung Lee; Jooryung Huh; Joon-Won Kang; Dong Yeol Shin; Dae-Hee Kim
Journal:  Korean J Intern Med       Date:  2016-02-02       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.